pBabe EGFR insertionH Citations (2)

Originally described in: Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors.
Yuza Y, Glatt KA, Jiang J, Greulich H, Minami Y, Woo MS, Shimamura T, Shapiro G, Lee JC, Ji H, Feng W, Chen TH, Yanagisawa H, Wong KK, Meyerson M Cancer Biol Ther. 2007 May . 6(5):661-7. PubMed Journal

---

Articles Citing pBabe EGFR insertionH

Articles
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations. Lee Y, Kim TM, Kim DW, Kim S, Kim M, Keam B, Ku JL, Heo DS. J Thorac Oncol. 2019 May 17. pii: S1556-0864(19)30369-7. doi: 10.1016/j.jtho.2019.05.006. PubMed
FGFR leads to sustained activation of STAT3 to mediate resistance to EGFR-TKIs treatment. Song X, Tang W, Peng H, Qi X, Li J. Invest New Drugs. 2021 Oct;39(5):1201-1212. doi: 10.1007/s10637-021-01061-1. Epub 2021 Apr 7. PubMed

If you have published an article using this material, please email us at to have your article added to this page.